94K-63580-84144
3 vaccinations
4 coded responses
32 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 220 / VA
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- QFM-25746-85896
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-06-26
Registered in v-safe
-
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-06-30
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Unevaluable event — Feeling: Fair · Irritability/crying · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Mom and dad both tested positive for COVID todayMedDRA releases: 2024-11 · check-in free text available
-
2022-06-30
Report sent to call center — days 1–6 daily, dose 1, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-01
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Exposure to SARS-CoV-2 — Feeling: Good · Be unable to work or attend schoolFree text: Mom and Dad in household tested positive for CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-07-01
Call successfulParticipant prefers to complete VAERS report online
-
2022-07-02
Survey response — day 7, dose 1, under 3MedDRA: COVID-19 — Feeling: Fair · Fever · Irritability/crying · Be unable to work or attend schoolFree text: She has Covid 19MedDRA releases: 2024-11 · check-in free text available
- 2022-07-09
- 2022-07-16
-
2022-07-23
Dose 2 — Pfizer-BioNTech
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-08-06
- 2022-08-13
- 2022-08-20
- 2022-08-27
- 2022-09-03
-
2022-09-17
Dose 3 — Pfizer-BioNTech
-
2022-09-18
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Injection site erythema, Injection site rash — Feeling: Fair · Site: Redness · FeverFree text: Little red bumps around injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-09-20
- 2022-09-21
- 2022-09-23
- 2022-09-24
- 2022-10-01
- 2022-10-10
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-12-17
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-23 | Pfizer-BioNTech | No |
| 3 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Mom and dad both tested positive for COVID today
Systemic reaction (other): Mom and Dad in household tested positive for Covid
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): She has Covid 19
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Little red bumps around injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | COVID-19 | · | · | ✓ |
| SRO | Exposure to SARS-CoV-2 | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release